Skip to main content

Table 5 Factors associated with sex-difference in clinical outcome

From: Sex-differences in the management and clinical outcome among patients with acute coronary syndrome

Clinical outcome

CV mortality

Non-CV mortality

ADHF

Odds ratio and 95% CI

   

Unadjusted

2.57 (1.09–6.27)

1.60 (0.17–15.5)

1.65 (1.02–2.66)

Model 1

2.12 (1.04–4.39)

1.21 (0.33–8.96)

1.47 (0.95–2.08)

Model 2

1.62 (0.90–2.23)

1.08 (0.41–4.29)

1.25 (0.86–1.60)

Model 3

1.04 (0.78–1.44)

1.01 (0.43–2.63)

1.08 (0.73–1.24)

Model 4

0.70 (0.62–1.20)

0.79 (0.36–1.82)

0.77 (0.68–1.13)

Model 5

0.68 (0.57–1.13)

0.74 (0.35–1.76)

0.74 (0.64–1.08)

Model 6

0.42 (0.37–1.02)

0.65 (0.40–1.61)

0.63 (0.55–1.01)

  1. Model 1: age; Model 2: model 1 plus educational attainment, and health insurance; Model 3: model 2 plus symptom onset to emergency department, and using emergency medical service to emergency department; Model 4: model 3 plus ticagrelor loading, duration since arrived at emergency department to first ECG test, duration since arrival at emergency department to first Hs-cTNT test, and duration since arrival at emergency department to Cardiologist consultation; Model 5: model 4 plus ticagrelor, statins, betablocker, renin-angiotensin-system inhibitor, and antidiabetics; Model 6: model 5 plus ST-segment elevation myocardial infarction, duration since symptom onset to undergo PCI, number of coronary arteries ≥ 70% stenosis, lesion length and location, post-PCI TIMI flow, and glycoprotein IIb/IIIa inhibitor
  2. CV, cardiovascular; ADHF, acute decompensated heart failure